这是一篇来自已证抗体库的有关人类 FLT3的综述,是根据20篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合FLT3 抗体。
FLT3 同义词: CD135; FLK-2; FLK2; STK1

BioLegend
小鼠 单克隆(BV10A4H2)
  • mass cytometry; 人类; 图 1b, 1d, s2
BioLegend FLT3抗体(Biolegend, BV10A4H2)被用于被用于mass cytometry在人类样本上 (图 1b, 1d, s2). Cell Rep (2019) ncbi
小鼠 单克隆(BV10A4H2)
  • 流式细胞仪; 人类; 1:10; 图 3d
BioLegend FLT3抗体(Biolegend, 313306)被用于被用于流式细胞仪在人类样本上浓度为1:10 (图 3d). Nat Commun (2019) ncbi
小鼠 单克隆(BV10A4H2)
  • 流式细胞仪; 人类; 图 1a
BioLegend FLT3抗体(biolegend, BV10A4H2)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2017) ncbi
小鼠 单克隆(BV10A4H2)
  • 流式细胞仪; 人类; 1:25; 图 1b
BioLegend FLT3抗体(BioLegend, BV10A4H2)被用于被用于流式细胞仪在人类样本上浓度为1:25 (图 1b). Cell Transplant (2017) ncbi
小鼠 单克隆(BV10A4H2)
  • 免疫细胞化学; 人类; 图 6
BioLegend FLT3抗体(BioLegend, BV10A4H2)被用于被用于免疫细胞化学在人类样本上 (图 6). Oncogene (2016) ncbi
圣克鲁斯生物技术
小鼠 单克隆
  • 免疫沉淀; 人类; 图 2
圣克鲁斯生物技术 FLT3抗体(Santa Cruz Biotechnology, SF-1.340)被用于被用于免疫沉淀在人类样本上 (图 2). Iran J Basic Med Sci (2014) ncbi
小鼠 单克隆(SF1.340)
  • 免疫沉淀; 人类; 图 2
圣克鲁斯生物技术 FLT3抗体(Santa Cruz Biotechnology, SF-1.340)被用于被用于免疫沉淀在人类样本上 (图 2). Iran J Basic Med Sci (2014) ncbi
赛默飞世尔
小鼠 单克隆(BV10A4H2)
  • 流式细胞仪; 人类; 图 st12
赛默飞世尔 FLT3抗体(eBioscience, BV10A4H2)被用于被用于流式细胞仪在人类样本上 (图 st12). Science (2017) ncbi
小鼠 单克隆(BV10A4H2)
  • 流式细胞仪; 人类; 1:10; 图 6
赛默飞世尔 FLT3抗体(Caltag, MHCD13505)被用于被用于流式细胞仪在人类样本上浓度为1:10 (图 6). Stem Cells Dev (2009) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 3a
赛信通(上海)生物试剂有限公司 FLT3抗体(Cell Signaling, 3461)被用于被用于免疫印迹在人类样本上 (图 3a). J Exp Med (2018) ncbi
domestic rabbit 单克隆(30D4)
  • 免疫印迹; 小鼠; 图 s4f
赛信通(上海)生物试剂有限公司 FLT3抗体(Cell Signaling Technology, 3464S)被用于被用于免疫印迹在小鼠样本上 (图 s4f). Nat Med (2018) ncbi
domestic rabbit 单克隆(33G6)
  • 免疫印迹; 人类; 图 2d
赛信通(上海)生物试剂有限公司 FLT3抗体(Cell Signaling, 3474)被用于被用于免疫印迹在人类样本上 (图 2d). Leukemia (2017) ncbi
domestic rabbit 单克隆(30D4)
  • 免疫印迹; 人类; 1:1000; 图 2a
赛信通(上海)生物试剂有限公司 FLT3抗体(Cell Signaling, 3464)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2a). Sci Rep (2015) ncbi
domestic rabbit 单克隆(8F2)
  • 免疫印迹; 人类; 图 1
赛信通(上海)生物试剂有限公司 FLT3抗体(Cell signaling, 3462)被用于被用于免疫印迹在人类样本上 (图 1). J Cell Biol (2015) ncbi
小鼠 单克隆(54H1)
  • 免疫印迹; 人类; 图 1
赛信通(上海)生物试剂有限公司 FLT3抗体(Cell signaling, 3466)被用于被用于免疫印迹在人类样本上 (图 1). J Cell Biol (2015) ncbi
domestic rabbit 单克隆(8F2)
  • 免疫沉淀; 人类
赛信通(上海)生物试剂有限公司 FLT3抗体(Cell Signaling Technology, 3462)被用于被用于免疫沉淀在人类样本上. Mol Cancer Ther (2014) ncbi
碧迪BD
小鼠 单克隆(4G8)
  • 流式细胞仪; 人类; 图 s4c
碧迪BD FLT3抗体(BD Pharmigen, 4G8)被用于被用于流式细胞仪在人类样本上 (图 s4c). Science (2017) ncbi
小鼠 单克隆(4G8)
  • 流式细胞仪; 人类; 表 3
碧迪BD FLT3抗体(BD Pharmingen, 4G8)被用于被用于流式细胞仪在人类样本上 (表 3). Am J Pathol (2017) ncbi
小鼠 单克隆(4G8)
  • 流式细胞仪; 人类; 图 st1
碧迪BD FLT3抗体(BD, 558996)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(4G8)
  • 流式细胞仪; 人类; 图 s1a, s1b, s1c
碧迪BD FLT3抗体(BD, 4G8)被用于被用于流式细胞仪在人类样本上 (图 s1a, s1b, s1c). Science (2016) ncbi
小鼠 单克隆(4G8)
  • 流式细胞仪; 人类
碧迪BD FLT3抗体(Becton Dickinson, 4G8)被用于被用于流式细胞仪在人类样本上. J Leukoc Biol (2015) ncbi
小鼠 单克隆(4G8)
  • 流式细胞仪; 人类
碧迪BD FLT3抗体(BD, 558996)被用于被用于流式细胞仪在人类样本上. Leukemia (2013) ncbi
文章列表
  1. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed 出版商
  2. Pellin D, Loperfido M, Baricordi C, Wolock S, Montepeloso A, Weinberg O, et al. A comprehensive single cell transcriptional landscape of human hematopoietic progenitors. Nat Commun. 2019;10:2395 pubmed 出版商
  3. Mitchell K, Barreyro L, Todorova T, Taylor S, Antony Debré I, Narayanagari S, et al. IL1RAP potentiates multiple oncogenic signaling pathways in AML. J Exp Med. 2018;215:1709-1727 pubmed 出版商
  4. Mathew N, Baumgartner F, Braun L, O Sullivan D, Thomas S, Waterhouse M, et al. Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nat Med. 2018;24:282-291 pubmed 出版商
  5. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed 出版商
  6. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed 出版商
  7. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed 出版商
  8. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed 出版商
  9. Matsuoka Y, Takahashi M, Sumide K, Kawamura H, Nakatsuka R, Fujioka T, et al. CD34 Antigen and the MPL Receptor Expression Defines a Novel Class of Human Cord Blood-Derived Primitive Hematopoietic Stem Cells. Cell Transplant. 2017;26:1043-1058 pubmed 出版商
  10. Wu M, Hamaker M, Li L, Small D, Duffield A. DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells. Leukemia. 2017;31:688-696 pubmed 出版商
  11. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  12. Notta F, Zandi S, Takayama N, Dobson S, Gan O, Wilson G, et al. Distinct routes of lineage development reshape the human blood hierarchy across ontogeny. Science. 2016;351:aab2116 pubmed 出版商
  13. Ma S, Yang L, Niu T, Cheng C, Zhong L, Zheng M, et al. SKLB-677, an FLT3 and Wnt/β-catenin signaling inhibitor, displays potent activity in models of FLT3-driven AML. Sci Rep. 2015;5:15646 pubmed 出版商
  14. Xia H, Najafov A, Geng J, Galan Acosta L, Han X, Guo Y, et al. Degradation of HK2 by chaperone-mediated autophagy promotes metabolic catastrophe and cell death. J Cell Biol. 2015;210:705-16 pubmed 出版商
  15. Ahn J, Li J, Chen E, Kent D, Park H, Green A. JAK2V617F mediates resistance to DNA damage-induced apoptosis by modulating FOXO3A localization and Bcl-xL deamidation. Oncogene. 2016;35:2235-46 pubmed 出版商
  16. Mashkani B, Griffith R, Ashman L. Differences in growth promotion, drug response and intracellular protein trafficking of FLT3 mutants. Iran J Basic Med Sci. 2014;17:867-73 pubmed
  17. Bigley V, McGovern N, Milne P, Dickinson R, Pagan S, Cookson S, et al. Langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells. J Leukoc Biol. 2015;97:627-34 pubmed 出版商
  18. Keegan K, Li C, Li Z, Ma J, Ragains M, Coberly S, et al. Preclinical evaluation of AMG 925, a FLT3/CDK4 dual kinase inhibitor for treating acute myeloid leukemia. Mol Cancer Ther. 2014;13:880-9 pubmed 出版商
  19. Caldarelli A, Muller J, Paskowski Rogacz M, Herrmann K, Bauer R, Koch S, et al. A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signaling. Leukemia. 2013;27:2301-10 pubmed 出版商
  20. King F, Ritner C, Liszewski W, Kwan H, Pedersen A, Leavitt A, et al. Subpopulations of human embryonic stem cells with distinct tissue-specific fates can be selected from pluripotent cultures. Stem Cells Dev. 2009;18:1441-50 pubmed 出版商